Early Christmas Sale - Ends Soon!
-35% Off Everything
HCA Healthcare, Inc. (HCA)
Last Price$327.20.5%
Market Cap$100.7B
HCA overview
Crunching data... Almost there!
1W (3.3%)
1M (8.8%)
6M (10.1%)
YTD 10.9%
1Y 15.9%
3Y 26.7%
5Y 113.6%
10Y 330.7%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
HCA key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
HCA Intrinsic value
HCA Intrinsic value overview
HCA Historical intrinsic value
HCA Financials
HCA Income statement
Crunching data... Almost there!
HCA Balance sheet
Crunching data... Almost there!
HCA Cash flow statement
Crunching data... Almost there!
HCA Financial ratios
HCA Growth
Crunching data... Almost there!
HCA Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more HCA fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of HCA Healthcare, Inc. (HCA) stock?
As of today, intrinsic value of HCA Healthcare, Inc. is $463.0.
Is HCA Healthcare, Inc. (HCA) stock undervalued or overvalued?
As of today, HCA Healthcare, Inc. is undervalued by 52.5%, compared to the current market share price of $327.2.
What is HCA Healthcare, Inc. (HCA) stock rating?
As of today, HCA Healthcare, Inc. has a stock rating of 7 (out of 10), which is considered Great.
is HCA Healthcare, Inc. (HCA) a good stock to buy?
As of today, HCA Healthcare, Inc. has a Great stock rating, which is 52.5% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.